Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

NCT01605331 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT01605331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01605331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)
Lead sponsor
LG Life Sciences
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
September 30, 2010
Enrollment
132 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency